Diurnal's Seed VC - II Round

Diurnal raised a round of funding on March 19, 2012. Investors include Fusion IP.

Diurnal is a pharmaceutical company that creates hormone therapeutics using formulations and physiological treatment regimes of approved drugs. The company addresses the unmet clinical and patient nee…

Articles about Diurnal's Seed VC - II Round: